Alternatives to Origin

AI-guided drug discovery platform for tissue-targeted medicines.

AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.

AI platform for embryonic phenotyping that accelerates drug discovery and toxicology testing by automating analysis of embryos and organoids.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Leveraging the adaptive immune system to diagnose and treat disease.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered platform for understanding disease biology and accelerating drug discovery.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Developing engineered biologics to harness the immune system for disease treatment.

AI-driven drug discovery platform for rapid development of novel therapeutics.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

Mapping cell-cell communication at scale in human tissue.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Biotechnology company focused on developing treatments for rare metabolic diseases.